Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

  • ID: 4402002
  • Report
  • 638 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • 2X Oncology Inc
  • BioMarker Strategies LLC
  • Eventus Diagnostics Inc
  • Leica Biosystems GmbH
  • OTraces Inc.
  • Target Discovery Inc
  • MORE
Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

Summary

The Medical Devices sector report, “Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Breast Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Breast Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Breast Cancer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Breast Cancer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to buy
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Breast Cancer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 2X Oncology Inc
  • BioMarker Strategies LLC
  • Eventus Diagnostics Inc
  • Leica Biosystems GmbH
  • OTraces Inc.
  • Target Discovery Inc
  • MORE
1 Table of Contents
2 Introduction
2.1 Breast Cancer Diagnostic Tests Overview
3 Products under Development
3.1 Breast Cancer Diagnostic Tests - Pipeline Products by Stage of Development
3.2 Breast Cancer Diagnostic Tests - Pipeline Products by Territory
3.3 Breast Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
3.4 Breast Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
3.5 Breast Cancer Diagnostic Tests - Ongoing Clinical Trials
4 Breast Cancer Diagnostic Tests - Pipeline Products under Development by Companies
4.1 Breast Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development
4.2 Breast Cancer Diagnostic Tests - Pipeline Products by Stage of Development
5 Breast Cancer Diagnostic Tests Companies and Product Overview
5.1 2X Oncology Inc Company Overview
5.2 A&G Pharmaceutical Inc Company Overview
5.3 Abviva, Inc. Company Overview
5.4 Accelerated Medical Diagnostics Company Overview
5.5 Acobiom Company Overview
5.6 Affichem SA Company Overview
5.7 AIT Austrian Institute of Technology GmbH Company Overview
5.8 Albert Ludwigs University of Freiburg Company Overview
5.9 Alere Inc Company Overview
5.10 Almac Diagnostics Ltd Company Overview
5.11 Amarantus Bioscience Holdings Inc Company Overview
5.12 AngioGenex Inc Company Overview
5.13 ANGLE plc Company Overview
5.14 Anixa Diagnostics Corporation Company Overview
5.15 Armune BioScience Inc Company Overview
5.16 Arno Therapeutics Inc Company Overview
5.17 ArtemixRx Company Overview
5.18 Ascendant Diagnostics, LLC Company Overview
5.19 Assurance Biosciences, Inc. (Inactive) Company Overview
5.20 Atossa Genetics Inc Company Overview
5.21 Aurelium BioPharma Inc. Company Overview
5.22 Autoimmune Technologies LLC Company Overview
5.23 Avant Diagnostics, Inc. Company Overview
5.24 Ayanda Biosystems SA (Inactive) Company Overview
5.25 Baylor College of Medicine Company Overview
5.26 BCAL Diagnostics Pty Limited Company Overview
5.27 Becton Dickinson and Co Company Overview
5.28 Biocartis SA Company Overview
5.29 Biocrates Life Sciences AG Company Overview
5.30 Biodesix Inc Company Overview
5.31 BioGenex Laboratories Inc Company Overview
5.32 BioMarCare Technologies Ltd Company Overview
5.33 BioMark Diagnostics Inc. Company Overview
5.34 BioMarker Strategies LLC Company Overview
5.35 bioMerieux S.A. Company Overview
5.36 Biomoda, Inc. (Inactive) Company Overview
5.37 Bioprognos SL Company Overview
5.38 Biosceptre International Ltd Company Overview
5.39 BioSystems International Company Overview
5.40 BioTime Inc Company Overview
5.41 Caprion Biosciences Inc Company Overview
5.42 Celcuity LLC Company Overview
5.43 Cellanyx Diagnostics, Inc. Company Overview
5.44 CellMax Life Company Overview
5.45 CellXplore, Inc. Company Overview
5.46 Centro de Investigacion y Asistencia en Tecnologia y Diseno del Estado de Jalisco Company Overview
5.47 Cepheid Company Overview
5.48 Ceres Nanosciences Inc Company Overview
5.49 Cernostics Inc. Company Overview
5.50 China Sky One Medical Inc Company Overview
5.51 Chronix Biomedical Inc Company Overview
5.52 Clarient Inc Company Overview
5.53 Cleveland Diagnostics Inc. Company Overview
5.54 CompanDX Ltd. Company Overview
5.55 Courtagen Life Sciences Inc Company Overview
5.56 Da An Gene Co Ltd Company Overview
5.57 Dana-Farber Cancer Institute Inc Company Overview
5.58 Dartmouth College Company Overview
5.59 Diaxonhit SA Company Overview
5.60 Dublin City University Company Overview
5.61 Eventus Diagnostics Inc (Inactive) Company Overview
5.62 Exosomics Siena SpA Company Overview
5.63 Fahy Gurteen UK Ltd Company Overview
5.64 Fina Biotech SL Company Overview
5.65 Fluxion Biosciences Inc Company Overview
5.66 Fournira Optime Diagnostics Company Overview
5.67 French National Institute of Health and Medical Research Company Overview
5.68 Genome Diagnostics Pvt. Ltd. Company Overview
5.69 Genomic Health Inc Company Overview
5.70 GenomicTree Inc Company Overview
5.71 Genoptix Inc Company Overview
5.72 George Washington University Company Overview
5.73 German Cancer Research Center Company Overview
5.74 Ghent University Company Overview
5.75 GlycoZym Company Overview
5.76 H. Lee Moffitt Cancer Center & Research Institute Inc Company Overview
5.77 Hai Kang Life Corp Ltd Company Overview
5.78 Health Discovery Corp Company Overview
5.79 Hebrew University of Jerusalem Company Overview
5.80 Heragen Inc Company Overview
5.81 Hummingbird Diagnostics GmbH Company Overview
5.82 Ikonisys Inc Company Overview
5.83 Imagion Biosystems Inc Company Overview
5.84 Immunovia AB Company Overview
5.85 Insight Genetics Inc Company Overview
5.86 Institute of Cancer Research Company Overview
5.87 IRIS International Inc Company Overview
5.88 IV Diagnostics Inc Company Overview
5.89 John Hopkins University Company Overview
5.90 Jonakee Cancer Research, Inc. Company Overview
5.91 Kailos Genetics, Inc. Company Overview
5.92 Kalgene Pharmaceuticals Inc Company Overview
5.93 King Abdullah University of Science and Technology Company Overview
5.94 Leica Biosystems GmbH Company Overview
5.95 Louisville Bioscience, Inc. Company Overview
5.96 MabCure Inc. Company Overview
5.97 Matrix-Bio, Inc. Company Overview
5.98 MDNA Life Sciences Inc Company Overview
5.99 MDxHealth SA Company Overview
5.100 Medical Prognosis Institute A/S Company Overview
5.101 MEDITE Cancer Diagnostics Inc Company Overview
5.102 MedMira Inc. Company Overview
5.103 Metabolomic Technologies Inc Company Overview
5.104 MetaStat Inc Company Overview
5.105 Milagen Inc Company Overview
5.106 Molecular Warehouse Ltd Company Overview
5.107 Morphotek Inc Company Overview
5.108 Myriad Genetics Inc Company Overview
5.109 NanoString Technologies Inc Company Overview
5.110 National University of Ireland Galway Company Overview
5.111 New York University Company Overview
5.112 Newcastle University Company Overview
5.113 Novel Bio-spectrum Technologies Inc (Inactive) Company Overview
5.114 Nuclea Biotechnologies Inc. (Inactive) Company Overview
5.115 Nuvera Biosciences Inc Company Overview
5.116 Olink Proteomics AB Company Overview
5.117 Olympia Diagnostics, Inc Company Overview
5.118 Oncimmune (USA) LLC Company Overview
5.119 OncoCyte Corp Company Overview
5.120 Onconome, Inc. (Inactive) Company Overview
5.121 OncoStem Diagnostics Pvt. Ltd Company Overview
5.122 OncoVista Innovative Therapies Inc Company Overview
5.123 On-Q-ity, Inc. (Inactive) Company Overview
5.124 Orion Genomics LLC Company Overview
5.125 OTraces Inc. Company Overview
5.126 Oxford Impedance Diagnostics Ltd Company Overview
5.127 PeriRx LLC Company Overview
5.128 Power3 Medical Products, Inc. Company Overview
5.129 Precision Biologics Inc Company Overview
5.130 PreMD Inc (Inactive) Company Overview
5.131 Princeton University Company Overview
5.132 Proplex Technologies Llc Company Overview
5.133 Protagen AG Company Overview
5.134 Proteome Sciences Plc Company Overview
5.135 Proteomika Company Overview
5.136 Provista Diagnostics Inc Company Overview
5.137 Purdue University Company Overview
5.138 Qiagen NV Company Overview
5.139 Quest Diagnostics Inc Company Overview
5.140 Rna Diagnostics Inc. Company Overview
5.141 Roche Diagnostics International Ltd Company Overview
5.142 Rosetta Genomics Ltd Company Overview
5.143 Royal College of Surgeons in Ireland Company Overview
5.144 RWTH Aachen University Company Overview
5.145 Savicell Diagnostic Ltd. Company Overview
5.146 Selventa Inc Company Overview
5.147 Sengenics International Pte Ltd Company Overview
5.148 Siamab Therapeutics Inc Company Overview
5.149 Siemens Healthcare GmbH Company Overview
5.150 Soricimed Biopharma Inc Company Overview
5.151 Target Discovery Inc (Inactive) Company Overview
5.152 Taxor Diagnostics, LLC Company Overview
5.153 TechnoGenesys, Inc. Company Overview
5.154 Treos Bio Inc Company Overview
5.155 Trinity College Dublin Company Overview
5.156 Universal Diagnostics SL Company Overview
5.157 University of Alberta Company Overview
5.158 University of Bergen Company Overview
5.159 University of Bonn Company Overview
5.160 University of California Riverside Company Overview
5.161 University of California San Diego Company Overview
5.162 University of Chicago Company Overview
5.163 University of Colorado Company Overview
5.164 University of Iowa Company Overview
5.165 University of Kansas Company Overview
5.166 University of Lyon Company Overview
5.167 University of Maryland Baltimore Company Overview
5.168 University of Missouri Company Overview
5.169 University of Nebraska Company Overview
5.170 University of Oxford Company Overview
5.171 University of Pittsburgh Company Overview
5.172 University of South Florida Company Overview
5.173 University of Texas MD Anderson Cancer Center Company Overview
5.174 University of Wisconsin Madison Company Overview
5.175 US Biomarkers Inc Company Overview
5.176 Vermillion Inc Company Overview
5.177 Viomics Inc. Company Overview
5.178 Vitatex Inc. Company Overview
5.179 Vitruvian Biomedical Inc Company Overview
5.180 VolitionRX Ltd Company Overview
5.181 XEPTAGEN SpA Company Overview
5.182 Xiamen Zeesan Biotech Co.,Ltd Company Overview
5.183 Zetiq Technologies Ltd Company Overview
6 Breast Cancer Diagnostic Tests - Recent Developments
6.1 Sep 14, 2017: Industry Leaders Allergan and Sientra Invest in The American Society for Aesthetic Plastic Surgery for Breast Implant Research
6.2 Sep 12, 2017: Cernostics Announces Leadership Team Expansion
6.3 Sep 06, 2017: MDxHealth Prepares for Growth with Executive Team Expansion
6.4 Sep 05, 2017: Rosetta Genomics to Reduce Operating and Other Expenses
6.5 Sep 04, 2017: Novartis announces CEO Joseph Jimenez to retire from Novartis in 2018. Vasant Narasimhan appointed CEO, effective February 1, 2018.
6.6 Aug 31, 2017: MDxHealth Announces First Half 2017 Financial Results
6.7 Aug 30, 2017: bioMerieux - First-Half 2017 Results
6.8 Aug 30, 2017: GSK responds to UK Life Sciences Industrial Strategy
6.9 Aug 29, 2017: Todos Medical Appoints Dr. Meir Silver as Vice President of Clinical Research and Regulatory Affairs
6.10 Aug 24, 2017: Novartis appoints Bertrand Bodson as Chief Digital Officer
6.11 Aug 24, 2017: Astellas Announces Personnel Changes and Organizational Changes
6.12 Aug 24, 2017: AroCell: Interim report, Q2 2017
6.13 Aug 24, 2017: Sectra Signs Breast Imaging PACS Contract With UC San Diego Health
6.14 Aug 22, 2017: Volition Signs Agreement with the Institute of Laboratory Medicine of the Technical University of Munich, Germany, to assist in securing large trials in a range of cancers
6.15 Aug 18, 2017: District Court Issues Final Judgment - Retractable Technologies v. Becton, Dickinson
6.16 Aug 15, 2017: GeneNews Announces Q2-2017 Financial Results & Provides Progress Update
6.17 Aug 14, 2017: MEDITE Cancer Diagnostics Reports 2017 Second Quarter and First Six Month Financial Results
6.18 Aug 14, 2017: Atossa Genetics Announces Second Quarter 2017 Financial Results And Provides Company Update
6.19 Aug 10, 2017: Biocept Reports Second Quarter 2017 Financial Results
6.20 Aug 09, 2017: VolitionRx Announces Second Quarter 2017 Financial Results and Business Update
6.21 Aug 08, 2017: HTG Molecular Diagnostics Reports Second Quarter 2017 Results
6.22 Aug 07, 2017: MDxHealth Appoints Seasoned EVP to Lead Sales Force Expansion
6.23 Aug 03, 2017: BD Announces Results For 2017 Third Fiscal Quarter
6.24 Aug 02, 2017: Clovis Oncology Announces Second Quarter 2017 Operating Results
6.25 Aug 01, 2017: Successful DRP prediction of patients treated with 2X-121, the PARP inhibitor recently licensed from Eisai
6.26 Aug 01, 2017: Pfizer Reports Second-Quarter 2017 Results
6.27 Aug 01, 2017: Proteome Sciences: Directorate changes
6.28 Aug 01, 2017: Genomic Health Announces Second Quarter 2017 Financial Results and Reports Recent Business Progress
6.29 Aug 01, 2017: Foundation Medicine Announces 2017 Second Quarter Results and Recent Highlights
7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Breast Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Table 2: Breast Cancer Diagnostic Tests - Pipeline Products by Territory
Table 3: Breast Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
Table 4: Breast Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
Table 5: Breast Cancer Diagnostic Tests - Ongoing Clinical Trials
Table 6: Breast Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development
Table 7: Breast Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Table 8: 2X Oncology Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: 2X-121 Companion Diagnostic Assay - Product Status
Table 10: 2X-121 Companion Diagnostic Assay - Product Description
Table 11: A&G Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Onco 88 - Breast Cancer - Product Status
Table 13: Onco 88 - Breast Cancer - Product Description
Table 14: OncoStain 88 - Breast Cancer - Product Status
Table 15: OncoStain 88 - Breast Cancer - Product Description
Table 16: Abviva, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 17: Diagnostic Assay - Mammastatin - Product Status
Table 18: Diagnostic Assay - Mammastatin - Product Description
Table 19: Accelerated Medical Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Companion Diagnostic Test - Oxaliplatin - Product Status
Table 21: Companion Diagnostic Test - Oxaliplatin - Product Description
Table 22: Acobiom Pipeline Products & Ongoing Clinical Trials Overview
Table 23: Companion Diagnostic Test - Breast Cancer - Product Status
Table 24: Companion Diagnostic Test - Breast Cancer - Product Description
Table 25: Companion Diagnostic Test - Triple Negative Breast Cancer - Product Status
Table 26: Companion Diagnostic Test - Triple Negative Breast Cancer - Product Description
Table 27: Diagnostic/Prognostic Assay - Breast Cancer - Product Status
Table 28: Diagnostic/Prognostic Assay - Breast Cancer - Product Description
Table 29: Affichem SA Pipeline Products & Ongoing Clinical Trials Overview
Table 30: AF300 Based Chromatographic Kit - Product Status
Table 31: AF300 Based Chromatographic Kit - Product Description
Table 32: AF300 Based Enzymatic Immunoassay Kit - Product Status
Table 33: AF300 Based Enzymatic Immunoassay Kit - Product Description
Table 34: AIT Austrian Institute of Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 35: Diagnostic Assay - Breast Cancer - Product Status
Table 36: Diagnostic Assay - Breast Cancer - Product Description
Table 37: Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview
Table 38: mRNA Based Diagnostic Assay - Breast Cancer - Product Status
Table 39: mRNA Based Diagnostic Assay - Breast Cancer - Product Description
Table 40: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 41: NMP66 Test - Product Status
Table 42: NMP66 Test - Product Description
Table 43: Almac Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 44: DNA Damage Response Deficiency Assay - Breast Cancer - Product Status
Table 45: DNA Damage Response Deficiency Assay - Breast Cancer - Product Description
Table 46: Amarantus Bioscience Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 47: NuroPro - Breast Cancer - Product Status
Table 48: NuroPro - Breast Cancer - Product Description
Table 49: AngioGenex Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Diagnostic/Prognostic/Surrogate Marker Test - Breast Cancer - Product Status
Table 51: Diagnostic/Prognostic/Surrogate Marker Test - Breast Cancer - Product Description
Table 52: Id1 Surrogate Marker Diagnostic Or Prognostic Test - Product Status
Table 53: Id1 Surrogate Marker Diagnostic Or Prognostic Test - Product Description
Table 54: Id2 Surrogate Marker Diagnostic Or Prognostic Test - Product Status
Table 55: Id2 Surrogate Marker Diagnostic Or Prognostic Test - Product Description
Table 56: Id3 Surrogate Marker Diagnostic or Prognostic Test - Product Status
Table 57: Id3 Surrogate Marker Diagnostic or Prognostic Test - Product Description
Table 58: Id4 Surrogate Marker Diagnostic Or Prognostic Test - Product Status
Table 59: Id4 Surrogate Marker Diagnostic Or Prognostic Test - Product Description
Table 60: ANGLE plc Pipeline Products & Ongoing Clinical Trials Overview
Table 61: Parsortix-Based Test - Breast Cancer - Product Status
Table 62: Parsortix-Based Test - Breast Cancer - Product Description
Table 63: Anixa Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 64: Biomarker Test - Breast Cancer - Product Status
Table 65: Biomarker Test - Breast Cancer - Product Description
Table 66: Armune BioScience Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 67: Diagnostic Test - Breast Cancer - Product Status
Table 68: Diagnostic Test - Breast Cancer - Product Description
Table 69: Arno Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 70: Activated Estrogen Receptor Biomarker Assay - Product Status
Table 71: Activated Estrogen Receptor Biomarker Assay - Product Description
Table 72: Onapristone Companion Diagnostic Assay - Breast Cancer - Product Status
Table 73: Onapristone Companion Diagnostic Assay - Breast Cancer - Product Description
Table 74: ArtemixRx Pipeline Products & Ongoing Clinical Trials Overview
Table 75: ArtemixRx Prognostic Test - Breast Cancer - Product Status
Table 76: ArtemixRx Prognostic Test - Breast Cancer - Product Description
Table 77: Ascendant Diagnostics, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 78: MelodyDX - Product Status
Table 79: MelodyDX - Product Description
Table 80: Assurance Biosciences, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 81: Salivary-Based Assay - Breast Cancer - Product Status
Table 82: Salivary-Based Assay - Breast Cancer - Product Description
Table 83: Atossa Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 84: ArgusCYTE Breast Health Test - Product Status
Table 85: ArgusCYTE Breast Health Test - Product Description
Table 86: Companion Diagnostic Test - Breast Cancer - Product Status
Table 87: Companion Diagnostic Test - Breast Cancer - Product Description
Table 88: Companion Diagnostic Test - PED - Product Status
Table 89: Companion Diagnostic Test - PED - Product Description
Table 90: Next Generation MASCT System - Product Status
Table 91: Next Generation MASCT System - Product Description
Table 92: NextCYTE Breast Cancer Test - Product Status
Table 93: NextCYTE Breast Cancer Test - Product Description
Table 94: Aurelium BioPharma Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 95: Breast Cancer Screening Test - Product Status
Table 96: Breast Cancer Screening Test - Product Description
Table 97: MMD ELISA Test - Breast Cancer - Product Status
Table 98: MMD ELISA Test - Breast Cancer - Product Description
Table 99: Autoimmune Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 100: Diagnostic Assay - Breast Cancer - Product Status
Table 101: Diagnostic Assay - Breast Cancer - Product Description
Table 102: Avant Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 103: Theralink mTOR Phosphoprotein Assay - Breast Cancer - Product Status
Table 104: Theralink mTOR Phosphoprotein Assay - Breast Cancer - Product Description
Table 105: Ayanda Biosystems SA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 106: Diagnostic Test - Breast Cancer - Product Status
Table 107: Diagnostic Test - Breast Cancer - Product Description
Table 108: Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
Table 109: Mitochondria-Regulated Cancer Signature - Breast Cancer - Product Status
Table 110: Mitochondria-Regulated Cancer Signature - Breast Cancer - Product Description
Table 111: BCAL Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview
Table 112: BCAL Test - Breast Cancer - Product Status
Table 113: BCAL Test - Breast Cancer - Product Description
Table 114: Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview
Table 115: Diagnostic Test - Breast Cancer - Product Status
Table 116: Diagnostic Test - Breast Cancer - Product Description
Table 117: Biocartis SA Pipeline Products & Ongoing Clinical Trials Overview
Table 118: Idylla Liquid Biopsy Test - Breast Cancer - Product Status
Table 119: Idylla Liquid Biopsy Test - Breast Cancer - Product Description
Table 120: Idylla Solid Biopsy Test - Breast Cancer - Product Status
Table 121: Idylla Solid Biopsy Test - Breast Cancer - Product Description
Table 122: Biocrates Life Sciences AG Pipeline Products & Ongoing Clinical Trials Overview
Table 123: Metabolomic Biomarker Assay - Breast Cancer - Product Status
Table 124: Metabolomic Biomarker Assay - Breast Cancer - Product Description
Table 125: Biodesix Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 126: VeriStrat - Breast Cancer - Product Status
Table 127: VeriStrat - Breast Cancer - Product Description
Table 128: BioGenex Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 129: IHC System - Breast Cancer - Product Status
Table 130: IHC System - Breast Cancer - Product Description
Table 131: BioMarCare Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 132: Breast PARpanel Biopsy - Product Status
Table 133: Breast PARpanel Biopsy - Product Description
Table 134: Breast PARpanel Blood - Product Status
Table 135: Breast PARpanel Blood - Product Description
Table 136: BioMark Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 137: Metabolomics-based Diagnostic Assay - Breast Cancer - Product Status
Table 138: Metabolomics-based Diagnostic Assay - Breast Cancer - Product Description
Table 139: BioMarker Strategies LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 140: Ex Vivo Biomarker Test - Breast Cancer - Product Status
Table 141: Ex Vivo Biomarker Test - Breast Cancer - Product Description
Table 142: bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview
Table 143: Companion Diagnostic Test - Hormone-Dependent Breast Cancer - Product Status
Table 144: Companion Diagnostic Test - Hormone-Dependent Breast Cancer - Product Description
Table 145: Biomoda, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 146: CyPath Diagnostic Assay - Breast Cancer - Product Status
Table 147: CyPath Diagnostic Assay - Breast Cancer - Product Description
Table 148: Bioprognos SL Pipeline Products & Ongoing Clinical Trials Overview
Table 149: MBDAA Breast Cancer Test - Product Status
Table 150: MBDAA Breast Cancer Test - Product Description
Table 151: Biosceptre International Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 152: Breast Cancer IHC Diagnostic Test - Product Status
Table 153: Breast Cancer IHC Diagnostic Test - Product Description
Table 154: BioSystems International Pipeline Products & Ongoing Clinical Trials Overview
Table 155: Diagnostic Test - Breast Cancer - Product Status
Table 156: Diagnostic Test - Breast Cancer - Product Description
Table 157: BioTime Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 158: Confirmatory Diagnostic Blood Test - Breast Cancer - Product Status
Table 159: Confirmatory Diagnostic Blood Test - Breast Cancer - Product Description
Table 160: Caprion Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 161: Diagnostic Assay - Breast Cancer - Product Status
Table 162: Diagnostic Assay - Breast Cancer - Product Description
Table 163: Celcuity LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 164: CELx HSF Test - Product Status
Table 165: CELx HSF Test - Product Description
Table 166: CELx Test - Breast Cancer - Product Status
Table 167: CELx Test - Breast Cancer - Product Description
Table 168: Cellanyx Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview

List of Figures
Figure 1: Breast Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Figure 2: Breast Cancer Diagnostic Tests - Pipeline Products by Territory
Figure 3: Breast Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
Figure 4: Breast Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
Figure 5: Breast Cancer Diagnostic Tests - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • 2X Oncology Inc
  • A&G Pharmaceutical Inc
  • Abviva, Inc.
  • Accelerated Medical Diagnostics
  • Acobiom
  • Affichem SA
  • AIT Austrian Institute of Technology GmbH
  • Albert Ludwigs University of Freiburg
  • Alere Inc
  • Almac Diagnostics Ltd
  • Amarantus Bioscience Holdings Inc
  • AngioGenex Inc
  • ANGLE plc
  • Anixa Diagnostics Corporation
  • Armune BioScience Inc
  • Arno Therapeutics Inc
  • ArtemixRx
  • Ascendant Diagnostics, LLC
  • Assurance Biosciences, Inc.
  • Atossa Genetics Inc
  • Aurelium BioPharma Inc.
  • Autoimmune Technologies LLC
  • Avant Diagnostics, Inc.
  • Ayanda Biosystems SA
  • Baylor College of Medicine
  • BCAL Diagnostics Pty Limited
  • Becton Dickinson and Co
  • Biocartis SA
  • Biocrates Life Sciences AG
  • Biodesix Inc
  • BioGenex Laboratories Inc
  • BioMarCare Technologies Ltd
  • BioMark Diagnostics Inc.
  • BioMarker Strategies LLC
  • bioMerieux S.A.
  • Biomoda, Inc.
  • Bioprognos SL
  • Biosceptre International Ltd
  • BioSystems International
  • BioTime Inc
  • Caprion Biosciences Inc
  • Celcuity LLC
  • Cellanyx Diagnostics, Inc.
  • CellMax Life
  • CellXplore, Inc.
  • Centro de Investigacion y Asistencia en Tecnologia y Diseno del Estado de Jalisco
  • Cepheid
  • Ceres Nanosciences Inc
  • Cernostics Inc.
  • China Sky One Medical Inc
  • Chronix Biomedical Inc
  • Clarient Inc
  • Cleveland Diagnostics Inc.
  • CompanDX Ltd.
  • Courtagen Life Sciences Inc
  • Da An Gene Co Ltd
  • Dana-Farber Cancer Institute Inc
  • Dartmouth College
  • Diaxonhit SA
  • Dublin City University
  • Eventus Diagnostics Inc
  • Exosomics Siena SpA
  • Fahy Gurteen UK Ltd
  • Fina Biotech SL
  • Fluxion Biosciences Inc
  • Fournira Optime Diagnostics
  • French National Institute of Health and Medical Research
  • Genome Diagnostics Pvt. Ltd.
  • Genomic Health Inc
  • GenomicTree Inc
  • Genoptix Inc
  • George Washington University
  • German Cancer Research Center
  • Ghent University
  • GlycoZym
  • H. Lee Moffitt Cancer Center & Research Institute Inc
  • Hai Kang Life Corp Ltd
  • Health Discovery Corp
  • Hebrew University of Jerusalem
  • Heragen Inc
  • Hummingbird Diagnostics GmbH
  • Ikonisys Inc
  • Imagion Biosystems Inc
  • Immunovia AB
  • Insight Genetics Inc
  • Institute of Cancer Research
  • IRIS International Inc
  • IV Diagnostics Inc
  • John Hopkins University
  • Jonakee Cancer Research, Inc.
  • Kailos Genetics, Inc.
  • Kalgene Pharmaceuticals Inc
  • King Abdullah University of Science and Technology
  • Leica Biosystems GmbH
  • Louisville Bioscience, Inc.
  • MabCure Inc.
  • Matrix-Bio, Inc.
  • MDNA Life Sciences Inc
  • MDxHealth SA
  • Medical Prognosis Institute A/S
  • MEDITE Cancer Diagnostics Inc
  • MedMira Inc.
  • Metabolomic Technologies Inc
  • MetaStat Inc
  • Milagen Inc
  • Molecular Warehouse Ltd
  • Morphotek Inc
  • Myriad Genetics Inc
  • NanoString Technologies Inc
  • National University of Ireland Galway
  • New York University
  • Newcastle University
  • Novel Bio-spectrum Technologies Inc
  • Nuclea Biotechnologies Inc.
  • Nuvera Biosciences Inc
  • Olink Proteomics AB
  • Olympia Diagnostics, Inc
  • Oncimmune (USA) LLC
  • OncoCyte Corp
  • Onconome, Inc.
  • OncoStem Diagnostics Pvt. Ltd
  • OncoVista Innovative Therapies Inc
  • On-Q-ity, Inc.
  • Orion Genomics LLC
  • OTraces Inc.
  • Oxford Impedance Diagnostics Ltd
  • PeriRx LLC
  • Power3 Medical Products, Inc.
  • Precision Biologics Inc
  • PreMD Inc
  • Princeton University
  • Proplex Technologies Llc
  • Protagen AG
  • Proteome Sciences Plc
  • Proteomika
  • Provista Diagnostics Inc
  • Purdue University
  • Qiagen NV
  • Quest Diagnostics Inc
  • Rna Diagnostics Inc.
  • Roche Diagnostics International Ltd
  • Rosetta Genomics Ltd
  • Royal College of Surgeons in Ireland
  • RWTH Aachen University
  • Savicell Diagnostic Ltd.
  • Selventa Inc
  • Sengenics International Pte Ltd
  • Siamab Therapeutics Inc
  • Siemens Healthcare GmbH
  • Soricimed Biopharma Inc
  • Target Discovery Inc
  • Taxor Diagnostics, LLC
  • TechnoGenesys, Inc.
  • Treos Bio Inc
  • Trinity College Dublin
  • Universal Diagnostics SL
  • University of Alberta
  • University of Bergen
  • University of Bonn
  • University of California Riverside
  • University of California San Diego
  • University of Chicago
  • University of Colorado
  • University of Iowa
  • University of Kansas
  • University of Lyon
  • University of Maryland Baltimore
  • University of Missouri
  • University of Nebraska
  • University of Oxford
  • University of Pittsburgh
  • University of South Florida
  • University of Texas MD Anderson Cancer Center
  • University of Wisconsin Madison
  • US Biomarkers Inc
  • Vermillion Inc
  • Viomics Inc.
  • Vitatex Inc.
  • Vitruvian Biomedical Inc
  • VolitionRX Ltd
  • XEPTAGEN SpA
  • Xiamen Zeesan Biotech Co.,Ltd
  • Zetiq Technologies Ltd
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll